{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T23:40:10Z","timestamp":1783381210467,"version":"3.54.6"},"reference-count":28,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2007,2]]},"DOI":"10.1097\/iae.0b013e318030a290","type":"journal-article","created":{"date-parts":[[2007,2,8]],"date-time":"2007-02-08T09:04:17Z","timestamp":1170925457000},"page":"150-158","source":"Crossref","is-referenced-by-count":71,"title":["INTRAVITREAL ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY WITH PEGAPTANIB FOR ADVANCED VON HIPPEL-LINDAU DISEASE OF THE RETINA"],"prefix":"10.1097","volume":"27","author":[{"given":"SAM S.","family":"DAHR","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"MICHAEL","family":"CUSICK","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"HANNA","family":"RODRIGUEZ-COLEMAN","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"SUNIL K.","family":"SRIVASTAVA","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"DARBY J.","family":"THOMPSON","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W MARSTON","family":"LINEHAN","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"FREDERICK L.","family":"FERRIS","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"EMILY Y.","family":"CHEW","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-3-20210130","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1093\/qjmed\/77.2.1151","article-title":"Clinical features and natural history of von Hippel-Lindau disease.","volume":"77","author":"Maher","year":"1990","journal-title":"Q J Med"},{"key":"R2-3-20210130","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1016\/S0140-6736(03)13643-4","article-title":"von Hippel-Lindau disease.","volume":"361","author":"Lonser","year":"2003","journal-title":"Lancet"},{"key":"R3-3-20210130","doi-asserted-by":"crossref","first-page":"2478","DOI":"10.1002\/(SICI)1097-0142(19991201)86:11+<2478::AID-CNCR4>3.0.CO;2-5","article-title":"Von Hippel-Lindau syndrome. A pleomorphic condition.","volume":"86","author":"Friedrich","year":"1999","journal-title":"Cancer"},{"key":"R4-3-20210130","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S0039-6257(01)00245-4","article-title":"von Hippel-Lindau disease.","volume":"46","author":"Singh","year":"2001","journal-title":"Surv Ophthalmol"},{"key":"R5-3-20210130","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1001\/archinte.1976.03630070017007","article-title":"Von Hippel-Lindau disease: clinical and pathological manifestations in nine families with 50 affected members.","volume":"136","author":"Horton","year":"1976","journal-title":"Arch Intern Med"},{"key":"R6-3-20210130","first-page":"133","article-title":"Von Hippel-Lindau disease in a Newfoundland kindred.","volume":"134","author":"Green","year":"1986","journal-title":"CMAJ"},{"key":"R7-3-20210130","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1097\/00006982-198606040-00010","article-title":"Von Hippel-Lindau disease: case report of a patient with spontaneous regression of a retinal angioma.","volume":"6","author":"Whitson","year":"1986","journal-title":"Retina"},{"key":"R8-3-20210130","first-page":"3067","article-title":"Retinal hemangioblastoma in von Hippel-Lindau disease: a clinical and molecular study.","volume":"43","author":"Dollfus","year":"2002","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R9-3-20210130","doi-asserted-by":"crossref","first-page":"2240","DOI":"10.1016\/S0161-6420(00)00422-X","article-title":"Juxtapapillary capillary hemangiomas. Clinical features and visual acuity outcomes.","volume":"107","author":"McCabe","year":"2000","journal-title":"Ophthalmology"},{"key":"R10-3-20210130","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1126\/science.8493574","article-title":"Identification of the von Hippel-Lindau disease tumor suppressor gene.","volume":"260","author":"Latif","year":"1993","journal-title":"Science"},{"key":"R11-3-20210130","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1038\/20459","article-title":"The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis.","volume":"399","author":"Maxwell","year":"1999","journal-title":"Nature"},{"key":"R12-3-20210130","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1038\/nrc885","article-title":"Molecular basis of the VHL hereditary cancer syndrome.","volume":"2","author":"Kaelin","year":"2002","journal-title":"Nat Rev Cancer"},{"key":"R13-3-20210130","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S1350-9462(02)00043-5","article-title":"Vascular endothelial growth factors and angiogenesis in eye disease.","volume":"22","author":"Witmer","year":"2003","journal-title":"Prog Retin Eye Res"},{"key":"R14-3-20210130","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1023\/A:1008213320642","article-title":"Elevated ocular levels of vascular endothelial growth factor in patients with von Hippel-Lindau disease.","volume":"8","author":"Los","year":"1997","journal-title":"Ann Oncol"},{"key":"R15-3-20210130","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1001\/archopht.117.5.625","article-title":"VHL gene deletion and enhanced VEGF gene expression detected in the stromal cells of retinal angioma.","volume":"117","author":"Chan","year":"1999","journal-title":"Arch Ophthalmol"},{"key":"R16-3-20210130","doi-asserted-by":"crossref","first-page":"S32","DOI":"10.1634\/theoncologist.5-suppl_1-32","article-title":"von Hippel-Lindau syndrome: target for anti-vascular endothelial growth factor (VEGF) receptor therapy.","volume":"5","author":"Harris","year":"2000","journal-title":"Oncologist"},{"key":"R17-3-20210130","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1016\/S0161-6420(02)01159-4","article-title":"Rapid and durable recovery of visual function in a patient with von Hippel-Lindau syndrome after systemic therapy with vascular endothelial growth factor receptor inhibitor su5416.","volume":"109","author":"Aiello","year":"2002","journal-title":"Ophthalmology"},{"key":"R18-3-20210130","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/S0002-9394(03)00101-6","article-title":"Treatment of von Hippel-Lindau retinal hemangioblastoma by the vascular endothelial growth factor receptor inhibitor SU5416 is more effective for associated macular edema than for hemangioblastomas.","volume":"136","author":"Girmens","year":"2003","journal-title":"Am J Ophthalmol"},{"key":"R19-3-20210130","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1001\/jama.291.8.943","article-title":"Antiangiogenic therapy for von Hippel-Lindau disease.","volume":"291","author":"Madhusudan","year":"2004","journal-title":"JAMA"},{"key":"R20-3-20210130","first-page":"1358","article-title":"Up-regulation of vascular endothelial growth factor and its receptors in von Hippel-Lindau disease-associated and sporadic hemangioblastomas.","volume":"55","author":"Wizigmann-Voos","year":"1995","journal-title":"Cancer Res"},{"key":"R21-3-20210130","doi-asserted-by":"crossref","first-page":"2805","DOI":"10.1056\/NEJMoa042760","article-title":"VEGF Inhibition Study in Ocular Neovascularization Clinical Trial Group. Pegaptanib for neovascular age-related macular degeneration.","volume":"351","author":"Gragoudas","year":"2004","journal-title":"N Engl J Med"},{"key":"R22-3-20210130","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1097\/00006982-200204000-00002","article-title":"Preclinical and phase 1A clinical evaluation of an anti-VEGF pegylated aptamer (pegaptanib) for the treatment of exudative age-related macular degeneration.","volume":"22","year":"2002","journal-title":"Retina"},{"key":"R23-3-20210130","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1016\/S0161-6420(03)00095-2","article-title":"Anti-vascular endothelial growth factor therapy for neovascular age-related macular degeneration: promises and pitfalls.","volume":"110","author":"Csaky","year":"2003","journal-title":"Ophthalmology"},{"key":"R24-3-20210130","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1001\/jama.293.12.1509","article-title":"Inhibitors of ocular neovascularization: promises and potential problems.","volume":"293","author":"van Wijngaarden","year":"2005","journal-title":"JAMA"},{"key":"R25-3-20210130","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.1167\/iovs.02-0807","article-title":"VEGF164 is proinflammatory in the diabetic retina.","volume":"44","author":"Ishida","year":"2003","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R26-3-20210130","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1167\/iovs.03-0106","article-title":"VEGF164(165) as the pathological isoform: differential leukocyte and endothelial responses through VEGFR1 and VEGFR2.","volume":"45","author":"Usui","year":"2004","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R27-3-20210130","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1001\/archopht.117.3.371","article-title":"Clinical characteristics of ocular angiomatosis in von Hippel-Lindau disease and correlation with germline mutation.","volume":"117","author":"Webster","year":"1999","journal-title":"Arch Ophthalmol"},{"key":"R28-3-20210130","first-page":"446","article-title":"Fifteen year review of treated cases of retinal angiomatosis.","volume":"83","author":"Annesley","year":"1977","journal-title":"Trans Am Acad Ophthalmol Otolaryngol"}],"container-title":["Retina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/IAE.0b013e318030a290","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T01:40:40Z","timestamp":1620956440000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00006982-200702000-00003"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,2]]},"references-count":28,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2007]]}},"URL":"https:\/\/doi.org\/10.1097\/iae.0b013e318030a290","relation":{},"ISSN":["0275-004X"],"issn-type":[{"value":"0275-004X","type":"print"}],"subject":[],"published":{"date-parts":[[2007,2]]}}}